Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

Chemo Controversy: An Inside Look at the 'Hot Chemotherapy Bath'

December 30th 2011

There is an ongoing debate in the oncology community about a treatment technique that involves cutting all visible cancer out of the abdomen and then flooding the cavity with heated chemotherapy drugs. The procedure -- known as cytoreductive surgery (CRS) -- followed by hyperthermic intraperitoneal chemotherapy (HIPEC), or a

Avastin Increases PFS in Patients With Ovarian Cancer

December 29th 2011

Bevacizumab (Avastin) improved progression-free survival (PFS) in patients with ovarian cancer but was not shown to affect overall survival (OS), according to a new study...

New FDA-Approved Oncology Drugs and Indications, 2011

December 29th 2011

This chart lists the new FDA-approved oncology drugs of 2011 and indications.

The Year's New Drugs: Integrating Advances of 2011 Into Treatment Plans

December 29th 2011

The FDA approved more new oncology drugs in 2011 than it has in a single year in more than a decade, thanks in part to priority review and streamlined evaluation procedures. While this is good news for patients, oncology and hematology specialists must tackle the challenges posed by integrating new therapies into treatment plans. Leading specialists give their perspectives on key issues.

Overcoming Resistance to Endocrine Therapies

December 29th 2011

Patients with hormone receptor-positive metastatic breast cancer (MBC) frequently respond to multiple lines of endocrine therapy but, unfortunately, resistance eventually develops.

Danish Study Finds No Link Between Cell Phone Use and Cancer

December 29th 2011

Danish investigators are reporting that long-term cell phone use does not appear to boost the risk of central nervous system (CNS) tumors.

Exelixis Finds Great Promise in Cabozantinib

December 28th 2011

The investigational compound cabozantinib (formerly known as XL184) has generated much excitement in recent years for its ability to target multiple pathways involved in the development of cancer.

Keeping Patients in Mind: Noted Breast Cancer Researcher Pursues Broad Notion of Personalized Medicine

December 28th 2011

One of a small group of scientists who had a hand in developing Herceptin (trastuzumab) for the treatment of breast cancer, Dr. Debu Tripathy's current work is focused on understanding why some patients are resistant to the drug, and how to create more effective therapies for them.

Doxil Shortage Expected to Last Another Year

December 27th 2011

Johnson and Johnson announced that they do not expect more Doxil (doxorubicin HCl liposome injection) to be available until sometime late in 2012...

Exploiting Oncogene Addiction and Immunogenicity May Be Path to Improved Results in HER2-Positive Breast Cancer

December 27th 2011

The approval of trastuzumab, targeted directly to the human epidermal growth factor receptor (HER2)-positive, was a major advance in extending the lives of women with HER2-positive breast cancer.

Room for Improvement: Reporting Near-Misses and Errors in Radiation Oncology

December 27th 2011

A new study presented at the 2011 annual meeting of the American Society for Radiation Oncology (ASTRO) found that 97% of radiation oncology team members believe they have a responsibility to report near-misses and errors...

The FDA Revokes

December 21st 2011

The FDA has broad authority to regulate food safety, as well as the safety, efficacy, and utilization of drugs and medical devices.

Day in the Life of an Oncology/Hematology Fellowship Program Director

December 15th 2011

Trainees have sat in this hot seat at the front of the room for decades. It's not really warm, of course. This is where the fellow sits who is asked to review the findings, come up with a differential diagnosis, and devise a plan for the case in question.

Interviewing 101: Tips for Landing Your First Post-Fellowship Position

December 15th 2011

Like all the other skills you've honed so finely over the years, interviewing can be mastered with the help of some solid tips, ample preparation, and a good dose of practice.

What Oncology and Hematology Fellows Can Do to Reduce Their Loan Debt

December 15th 2011

While debt from medical school loans is inevitable for most oncology and hematology fellows, there are strategies they can consider to lessen that burden.

Progenics Trims Staff to Focus on Oncology

November 30th 2011

Progenics Pharmaceuticals, Inc. is trimming its staff by 26% and cutting its infectious disease and virology programs so that it can focus solely on its oncology program.

Dr. Brufsky Advises Doctors on Avastin for Breast Cancer

November 18th 2011

Dr. Adam Brufsky from the University of Pittsburgh School of Medicine Advises Doctors on Bevacizumab (Avastin) for Breast Cancer

Dr. Woodruff on Oncofertility Insurance Coverage

November 2nd 2011

Dr. Teresa Woodruff from Feinberg School of Medicine, Northwestern University, Discusses Oncofertility Insurance Coverage

Loan Repayment Programs for Oncology/Hematology Fellows

October 31st 2011

Itâ€™s no surprise that you acquire significant debt during your medical training. Here are some ways to get those loans paid off.

The Biology of Burnout

October 31st 2011

Burnout is a recurring problem for overworked oncologists and hematologists. This article includes ideas to keep you healthy, engaged, and empathic.